Your browser doesn't support javascript.
loading
Do-it-yourself closed-loop systems for people living with type 1 diabetes.
Dowling, L; Wilmot, E G; Choudhary, P.
Afiliación
  • Dowling L; Diabetes UK, London, UK.
  • Wilmot EG; University Hospital of Derby and Burton NHS Foundation Trust, Derby, UK.
  • Choudhary P; Department of Diabetes, School of Life Course Sciences, King's College London, London, UK.
Diabet Med ; 37(12): 1977-1980, 2020 12.
Article en En | MEDLINE | ID: mdl-32420640
ABSTRACT
Growing numbers of people with type 1 diabetes are using do-it-yourself closed-loop systems. While these technologies are not approved by regulatory bodies and are not commercially available, users of the technology report improvements in HbA1c and time in range, and reduced burden of diabetes. Healthcare professionals have expressed their concern that legal or regulatory body actions could ensue if they support people who choose to use do-it-yourself closed-loop systems. Diabetes UK's position statements make recommendations that aim to provide guidance for both people with diabetes and healthcare professionals, based on the current professional and legal situation. They respect an individual's right to make their own informed decisions about their diabetes management, and recommend that they should have access to the technology they need for optimal diabetes management. People who wish to use do-it-yourself closed-loop systems should continue to receive support and care from their diabetes team. Healthcare professionals should engage in conversations around do-it-yourself closed-loop systems, if the issue is raised, to allow a balanced discussion of risks and benefits. However, healthcare professionals cannot recommend the use of do-it-yourself closed-loop systems because of a lack of regulatory body approval and robust, published research to support safety or effectiveness. People using this technology should be aware that they do so at their own risk. This position statement recognizes that the development of diabetes technology is a rapidly changing environment, and guidance around do-it-yourself systems is required from professional and regulatory bodies.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sistemas de Infusión de Insulina / Automonitorización de la Glucosa Sanguínea / Diabetes Mellitus Tipo 1 / Control Glucémico Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Diabet Med Asunto de la revista: ENDOCRINOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sistemas de Infusión de Insulina / Automonitorización de la Glucosa Sanguínea / Diabetes Mellitus Tipo 1 / Control Glucémico Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Diabet Med Asunto de la revista: ENDOCRINOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido